Industry Fury as UK Watchdog Curbs Alzheimer Drugs (Reuters


Reuters - Britain's cost-effectiveness health
watchdog said Tuesday it wants to limit access to the four main
drugs used to treat patients with Alzheimer's disease, to the
fury of pharmaceutical manufacturers.

Read more...